Klotho Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
2ndary - Private
Klotho Therapeutics General Information
Description
Operator of a biotechnology company intended to develop therapies targeting aging-related diseases. The company develops modified recombinant versions of the human protein using cell culture technology to mimic naturally occurring protein functions, enabling healthcare providers to address conditions such as cognitive decline, kidney disease, and cancer.
Contact Information
Website
www.klotho.comCorporate Office
- 123 Main Street
- San Diego, CA 92121
- United States
Corporate Office
- 123 Main Street
- San Diego, CA 92121
- United States
Klotho Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 01-Nov-2025 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 02-Nov-2017 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2017 | $20K | Completed | Startup | ||
| 1. Seed Round | $20K | $20K | Completed | Startup |
Klotho Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
Klotho Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Klotho Therapeutics Patents
Klotho Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12544350-B2 | Combinatorial antitumor treatment methods and related compositions, kits, and systems | Active | 08-Jul-2021 | ||
| US-20260191813-A1 | Combinatorial antitumor treatment methods and related compositions, kits, and systems | Pending | 08-Jul-2021 | ||
| EP-4366716-A1 | Novel combinatorial antitumor treatment methods and related compositions, kits, and systems | Pending | 08-Jul-2021 | ||
| EP-4366716-A4 | Novel combinatorial antitumor treatment methods and related compositions, kits, and systems | Pending | 08-Jul-2021 | ||
| US-20240277650-A1 | Novel combinatorial antitumor treatment methods and related compositions, kits, and systems | Active | 08-Jul-2021 | A61K31/216 |
Klotho Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Klotho Therapeutics FAQs
-
When was Klotho Therapeutics founded?
Klotho Therapeutics was founded in 2016.
-
Where is Klotho Therapeutics headquartered?
Klotho Therapeutics is headquartered in San Diego, CA.
-
What is the size of Klotho Therapeutics?
Klotho Therapeutics has 2 total employees.
-
What industry is Klotho Therapeutics in?
Klotho Therapeutics’s primary industry is Biotechnology.
-
Is Klotho Therapeutics a private or public company?
Klotho Therapeutics is a Private company.
-
What is Klotho Therapeutics’s current revenue?
The current revenue for Klotho Therapeutics is .
-
How much funding has Klotho Therapeutics raised over time?
Klotho Therapeutics has raised $10M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
